LFG
JAZZ icon

Larson Financial Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Larson Financial Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$80.9K Buy
428
+83
+24% +$14.5K ﹤0.01% 1094
2025
Q4 		$58.6K Buy
345
+40
+13% +$6.13K ﹤0.01% 1162
2025
Q3 		$40.2K Sell
305
-36
-11% -$4.32K ﹤0.01% 1251
2025
Q2 		$36.2K Buy
341
+243
+248% +$26.4K ﹤0.01% 1204
2025
Q1 		$12.2K Buy
98
+36
+58% +$4.7K ﹤0.01% 1558
2024
Q4 		$7.63K Buy
62
+56
+933% +$6.6K ﹤0.01% 1565
2024
Q3 		$668 Buy
6
+3
+100% +$329 ﹤0.01% 2068
2024
Q2 		$320 Hold
3
– – ﹤0.01% 1948
2024
Q1 		$361 Hold
3
– – ﹤0.01% 1586
2023
Q4 		$369 Hold
3
– – ﹤0.01% 1598
2023
Q3 		$388 Hold
3
– – ﹤0.01% 1598
2023
Q2 		$372 Hold
3
– – ﹤0.01% 1470
2023
Q1 		$439 Hold
3
– – ﹤0.01% 1422
2022
Q4 		$478 Hold
3
– – ﹤0.01% 1371
2022
Q3 		$0 Hold
3
– – ﹤0.01% 1347
2022
Q2 		$0 Hold
3
– – ﹤0.01% 1247
2022
Q1 		$0 Hold
3
– – ﹤0.01% 1111
2021
Q4 		$0 Buy
+3
New +$394 ﹤0.01% 1128
2020
Q1 		– Sell
-15
Closed -$2K – 595
2019
Q4 		$2K Hold
15
– – ﹤0.01% 455
2019
Q3 		$2K Hold
15
– – ﹤0.01% 437
2019
Q2 		$2K Hold
15
– – ﹤0.01% 389
2019
Q1 		$2K Hold
15
– – ﹤0.01% 380
2018
Q4 		$2K Buy
+15
New +$2.23K ﹤0.01% 359

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Larson Financial Group's JAZZ Position: Q1 2026 in Review

Larson Financial Group increased its Jazz Pharmaceuticals (JAZZ) stake by 24% in Q1 2026, buying an estimated $14.5K and bringing the position to 428 shares worth $80.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1094.

Larson Financial Group first reported a position in JAZZ in Q4 2018 and has held it in 23 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Larson Financial Group held 428 shares of Jazz Pharmaceuticals worth $80.9K as of Q1 2026.
  • Larson Financial Group bought 83 Jazz Pharmaceuticals shares in Q1 2026, an estimated $14.5K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #1094 holding.
  • Larson Financial Group first reported a position in Jazz Pharmaceuticals in Q4 2018 and has held it in 23 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.